78
AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was “rapidly transferring manufacturing” across the Atlantic.
AstraZeneca CEO doubles down on U.S. amid rumors of listing shift
